Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001219611 | SCV001391559 | uncertain significance | Multiple endocrine neoplasia, type 2 | 2019-04-17 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has been reported to affect RET protein function (PMID: 22837065). This variant has been observed in an individual with total colonic agaglionosis (PMID: 10946353). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glutamic acid with lysine at codon 734 of the RET protein (p.Glu734Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. |